Professional Documents
Culture Documents
PROGRAMME: BSBIO
LEVEL : 2.2
Plagiarism statement
I certify that this assignment/report is my own work, based on my personal study and/or research
and that I have acknowledged all material and sources used in its preparation, whether they be
books, articles, reports, lecture notes, and any other kind of document, electronic or personal
communication. I also certify that this assignment/report has not previously been submitted for
assessment in any other unit, except where specific permission has been granted from all unit
coordinators involved, or at any other time in this unit, and that I have not copied in part or whole or
otherwise plagiarised the work of other students and/or persons.
Question
Using examples, discuss the benefits and risks of plant
biotechnology. (25)
Plants undergo genetic modifications that alter their genetic make up and become
favourable to certain conditions, which are mostly beneficial to humans. The traits
these new varieties contain are most commonly insect resistance (cotton, corn),
herbicide resistance (soybean), and delayed fruit ripening (tomato). The benefits of
these initial transgenic crops are better weed and insect control, higher productivity,
and more flexible crop management. These benefits are advantageous mostly to
farmers and agribusinesses but there are also economic benefits to consumers in
terms of maintaining food production at low prices. The broader benefits is owed to
the environment and the community through a reduction in the use of pesticides
which contributes to a more sustainable agriculture and better food security. There
also is work in progress to use plants such as corn, potato, and banana as
minifactories for the production of vaccines and biodegradable plastics which will
prove very beneficial to the pharmaceutical industry and plastic industries.
Plant biotechnology also improves shelf life of food products for example transgenic
tomatoes with delayed softening can be vine ripened and shipped without damage.
This makes transportation of the crop product easier as well as gives consumers
access to nutritionally valuable whole foods.
Further advances in biotechnology will likely result in crops with a wider range of
traits, some of which are likely to be of more direct interest to consumers, for
example, by having traits that confer improved nutritional quality ( like the already
existing golden rice.) Crops with improved output traits could confer nutritional
benefits to millions of people who suffer from malnutrition and deficiency disorders.
Genes have been identified that can modify and enhance the composition of oils,
proteins, carbohydrates, and starch in food/feed grains and root crops. A gene
encoding beta carotene/vitamin A formation has been incorporated experimentally in
the golden rice. This would enhance the diets of the 180 million children who suffer
from the vitamin A deficiency that leads to 2 million deaths annually. Similarly,
introducing genes that increase available iron levels in rice three-fold is a potential
remedy for iron deficiency that affects more than 2 billion people and causes anemia
in about half that number.
The recent report of the Nuffield Council on Bioethics in the United Kingdom (1999)
concluded that there is a compelling moral imperative to enable emerging economies
to evaluate the use of new biotechnologies as tools to combat hunger and poverty.
The health effects of foods grown from genetically modified crop varieties
(sometimes called GM foods) depends on the specific content of the food itself and
may have either potentially beneficial or occasional harmful effects on human health.
For example, a GM food with a higher content of digestible iron is likely to have a
positive health effect if consumed by iron-deficient individuals. Alternatively, transfer
of genes from one species to another may also transfer allergic risk and these risks
need to be evaluated and identified prior to commercialization. Individuals allergic to
certain nuts, for example, need to know if genes conveying this trait are transferred
to other foods such as soybeans and would labelling be required if such crops were
to be commercialized. There is also some concern as to the potential health risks
from the use of antibiotic resistance markers in GM foods, although there is no
evidence of this.
Labelling also may be needed in some countries to identify other novel content
resulting from genetic modification for cultural and religious reasons or simply
because the consumers want to know what is the content of the food and how it was
produced to make an informed choice, independent of any health risks.
Amongst the potential ecological risks identified are increased weediness, due to
cross pollination whereby pollen from GM crops spreads to non-GM crops in nearby
fields. This may allow the spread of traits such as herbicide-resistance from
genetically modified plants to non target plants, with the latter potentially developing
into weeds. This ecological risk may be assessed when deciding if a GMO with a
given trait should be released into a particular environment, and if so, under what
conditions. Where such releases have been approved, the monitoring of the
behaviour of GMOs after their release is a rich field for future research in crop
ecology.
Other potential ecological risks stem from the widespread use of genetically modified
corn and cotton with insecticidal genes from Bacillus thuringiensis (the Bt genes).
This may lead to the development of resistance to Bt in insect populations exposed
to the GM crops. An attempt to manage this risk is being done in the early plantings
of GM crops by planting "refuge" sections of Bt-cotton fields with insect susceptible
varieties to reduce the opportunity of the insect population to evolve towards
resistance to the plants having the Bt gene for resistance (Gould, 1999). There also
may be a risk to nontarget species, such as birds and butterflies, from the plants with
Bt genes. The monitoring of these effects of new transgenic crops in the environment
and the devising of effective risk management approaches is an essential
component of further research in risk management.
Technology-Transcending Risks
Technology-transcending risks covers the social and ethical concerns that plant
biotechnology may potentially increase the prosperity gap between the rich and the
poor, both internationally and within individual societies, and that it is likely to
contribute to loss of biodiversity. There also are ethical concerns as to the moral
dimensions of patenting living organisms and the cross-species movement of genes.
These risks relate to the use of the technology, not the technology itself. The
management of these risks requires policies and practices that give consumers
choices while also promoting environmentally sustainable development through the
judicious use of new developments in science and technology.
To slow the continuing loss of biodiversity, the main tasks are the preservation of
tropical forests, mangroves and other wetlands, rivers, lakes, and coral reefs. The
fact that farmers replace traditional varieties with superior varieties does not
necessarily result in a loss of biodiversity. Varieties that are under pressure of
substitution also can be conserved through in vivo and in vitro strategies. Improved
governance and international support are necessary to limit loss of biodiversity.
Actually or potentially useful biological resources should not be lost simply because
we do not know or appreciate them at present (Leisinger, 1999).
Conclusion
Governments and other responsible parties should effectively communicate with the
public about the nature of new crop types and new crop varieties, about the unity of
life processes in all organisms, and about the risks and benefits of agricultural
biotechnology in their own country and internationally. There also is a need to
continually improve the transparency and broad participation in the decision making
processes in relation to biotechnology, the release of genetically modified organisms
into the environment, and the approval of genetically modified foods for commercial
use.
References.
4. http://usda.mannlib.cornell.edu/reports/nassr/field/pcp-bbp/pspl0302.pdf)